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Purpose: The aim of this study was to determine the clinical feasibility of using dehydro-
thermally cross-linked collagen membrane (DCM) for bone regeneration around peri-im-
plant dehiscence defects, and compare it with non-cross-linked native collagen membrane 
(NCM).
Methods: Dehiscence defects were investigated in twenty-eight patients. Defect width and 
height were measured by periodontal probe immediately following implant placement 
(baseline) and 16 weeks afterward. Membrane manipulation and maintenance were clini-
cally assessed by means of the visual analogue scale score at baseline. Changes in horizon-
tal thickness at 1 mm, 2 mm, and 3 mm below the top of the implant platform and the av-
erage bone density were assessed by cone-beam computed tomography at 16 weeks. Deg-
radation of membrane was histologically observed in the soft tissue around the implant 
prior to re-entry surgery.
Results: Five defect sites (two sites in the NCM group and three sites in the DCM group) 
showed soft-tissue dehiscence defects and membrane exposure during the early healing 
period, but there were no symptoms or signs of severe complications during the experi-
mental postoperative period. Significant clinical and radiological improvements were found 
in all parameters with both types of collagen membrane. Partially resorbed membrane leaf-
lets were only observed histologically in the DCM group.
Conclusions: These findings suggest that, compared with NCM, DCM has a similar clinical 
expediency and possesses more stable maintenance properties. Therefore, it could be used 
effectively in guided bone regeneration around dehiscence-type defects.
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INTRODUCTION
Guided bone regeneration (GBR) has become an indispensable technique for enhancing 
new bone formation around peri-implant dehiscence defects [1,2]. Non-cross-linked native 
collagen membrane (NCM) is the most widely used type of membrane in the GBR tech-
nique. It shows excellent biocompatibility with a low immune response, and has the advan-
tage of promoting wound healing by inducing fibroblast migration [3-5]. In addition, the 
bone regeneration capacity of NCM is similar to that of nonresorbable membrane [6]. De-
spite these advantages, the shortened functional period due to a loss of cell occlusiveness 
and greater susceptibility to degradation by periodontal bacteria may restrict bone regen-
eration when using NCM [7,8].
Various cross-linking methods have been investigated and developed with the aim of 
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improving the mechanical properties and compensating for the 
disadvantages of NCM [9]. Chemical and physical modifications 
are important for increasing the degree of cross-linking between 
collagen fibers, which varies significantly with the cross-linking 
method used [10]. However, all cross-linked membranes reportedly 
increase thermal stability, mechanical strength, and resistance to 
enzyme activity [11].
Chemically cross-linked collagen membrane reportedly exhibits 
biocompatibility with a minimal inflammatory response and has 
been used for GBR; however, several randomized controlled clinical 
studies have also demonstrated that it exerts significant adverse 
effects on bone regeneration [12-15]. For example, Becker et al. 
[14] reported that while chemically cross-linked collagen mem-
brane provides predictable bone augmentation, it is also frequently 
associated with premature membrane exposure and wound infec-
tions. In addition, Annen et al. [15] showed that chemically cross-
linked collagen membrane with an extended resorption time was 
associated with significantly more complications and a lower bone 
regeneration efficacy compared to NCM.
Dehydrothermal (DHT) treatment is a major physical modifica-
tion method used in the production of a cross-linking collagen 
matrix. In vitro studies have demonstrated that DHT cross-linked 
collagen membrane (DCM) exhibits a high tensile strength and re-
sistance to degradation, and reduced cytotoxic responses [16,17]. 
Rothamel et al. [18] showed that DCM and NCM have similar bio-
compatibility in rabbits, and that DCM provides an adequate envi-
ronment for bone remodeling with sufficient vascularization dur-
ing the initial healing phase as well as long-term structural stabili-
ty. However, despite these positive results in animal studies, few 
clinical and controlled human studies have assessed the efficacy 
and safety of DCM.
The aim of this study was to determine the clinical feasibility of 
DCM for use in bone regeneration around peri-implant dehiscence 
defects, and compare it with that of NCM.
 
MATERIALS AND METHODS
Study design
A randomized, single-blinded, single-center clinical trial was con-
ducted to evaluate the clinical feasibility and bone regeneration ca-
pacity around peri-implant dehiscence defects of two types of 
membrane. The study was approved by the Institutional Review 
Board (IRB) for Clinical Research at Dental Hospital of Yonsei Uni-
versity (approval no. 2-2013-0021). All patients provided written 
fully informed consent in accordance with IRB guidelines for enroll-
ment, and the study was conducted in accordance with the Decla-
ration of Helsinki and the Guidelines on Good Clinical Practice [19].
Study population
A total of 43 patients who needed single-tooth implant treat-
ment from August 2013 to October 2014 were included in this clin-
ical study. The following inclusion criteria were applied: (1) male or 
female aged ≥20 years, (2) healthy systemic condition (including 
well-controlled medical illnesses), (3) a vertical dehiscence defect 
(only on the buccal side) of ≥3 mm present immediately after im-
plant placement, (4) secure primary stability of the implant, and (5) 
no allergic reaction to collagen. The following exclusion criteria 
were applied: (1) severe or uncontrolled systemic disease, (2) ad-
vanced or untreated periodontitis, (3) pregnancy or breastfeeding, 
(4) history of radiation therapy to the head or neck, (5) hormones 
or bisphosphonate therapy affecting bone or connective tissue me-
tabolism, and (6) heavy smoking (>20 cigarettes/day).
Sample size calculation
The required sample size was determined using the two-sided t-
test at an alpha level of 0.05 and a statistical power of 80%. The 
threshold for differences in bone regeneration capacity between 
the NCM and DCM groups was set to 1.0 mm, and the standard 
deviation was assumed to be the same for both groups according 
to the results of a previous study [20,21]. These parameters result-
ed in a required sample size of 28 patients, and so 30 patients were 
enrolled (15 patients in each group) to account for a potential 
dropout rate of 10%. The statistical power was calculated using G* 
Power 3.1 (University of Duesseldorf, Germany) [22].
Randomization
Randomization took place after implant placement using online 
databases for clinical trials (Sealed Envelope™, sealedenvelope.
com). The 30 enrolled patients were assigned to either the NCM 
group (n=15) or the DCM group (n=15) according to computer-
generated random numbers. None of the patients knew whether 
they received the control or experimental membrane until after 
the end of the study.
Surgical procedures
All steps in the surgical procedures and all evaluation parameters 
were calibrated in training and calibration sessions. All patients re-
ceived antibiotics (amoxicillin 500 mg or roxithromycin 150mg 
daily), a single dose of analgesic (ibuprofen 200mg), and mouth-
wash (GUM Activital, Sunstar, Osaka, Japan) after implant surgery 
for 7 days. Full-thickness flaps were elevated, with vertical inci-
sions made when necessary. A surgical stent was prepared for the 
optimal implant position, and a sandblasted, large-grit,acid-etched 
(SLA) surface internal-type implant fixture was placed in accor-
dance with the manufacturer’s recommended protocol. A sealed 
randomization envelope was opened to allocate augmentation of 
the defect, with either porcine dermis-derived non-cross-linked 
type I and III collagen (BioGide® Geistlich Biomaterials, Wolhusen, 
Switzerland) or porcine pericardium-derived type I collagen mem-
brane (OssGuide®, Bioland, Cheongju, Korea) and xenograft bone 
substitutes (BioOss®, Geistlich Biomaterials, Wolhusen, Switzerland, 
and CollaOss®, Bioland, Cheongju, Korea). After implant placement 
in the ideal prosthetic position, the horizontal and vertical dehis-
cence defect was augmented. A collagen membrane was trimmed 
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so that it extended 2–3 mm from the defect margin. Flaps were 
sutured with 6-0 absorbable sutures (Monosyn 6–0, B. Braun Aes-
culap, Tuttlingen, Germany), with a horizontal periosteal releasing 
incision used where necessary to attain primary and tension-free 
closure of the flap. Follow-up was performed three times during 8 
weeks and additional care was arranged according to the needs of 
individual patients.
Clinical analysis
All horizontal and vertical defects were measured using a 15-mm 
UNC periodontal probe (CP 15 UNC, Hu-freidy, Chicago, IL, USA) at 
the time of implant installation and re-entry surgery. The same 
trained and calibrated examiners carried out all measurements. The 
following parameters were measured: (1) defect width (DW), mea-
sured as the linear distance between the widest points on the me-
dial and distal sides of the buccal aspect; (2) defect height (DH), 
measured as the linear distance from the top of the implant plat-
form to the initial bone-to-implant contact at the buccal aspect; (3) 
a change in the defect width (ΔDW), calculated as DW (re-entry 
surgery) – DW (baseline); and (4) a change in the defect height 
(ΔDH), calculated as DH (re-entry surgery) – DH (baseline).
The ease of manipulating and maintaining NCM and DCM in 
implant surgery was clinically assessed using scores on a visual an-
alog scale (VAS) that ranged from 0 (very good) to 10 (very poor). 
The following parameters were measured: (1) manipulation of the 
membrane, degree of hydrophilicity and handling during the GBR 
procedure; and (2) maintenance of augmented bone substitutes, 
and whether covering the membrane after augmentation with 
bone materials improved the stability.
Radiographic analysis
Cone-beam computed tomography (CBCT; Alphard Vega, Asahi 
Roentgen, Kyoto, Japan) was performed to assess the horizontal 
thickness (HT) immediately after augmentation and at the time of 
re-entry surgery. The following parameters were measured (Figure 
1): (1) horizontal thickness of horizontal augmented bone located 1, 
2, and 3 mm below the top of the implant platform (HT1, HT2, and 
HT3); (2) changes in horizontal thickness at each level, calculated as 
HT (re-entry surgery) – HT (baseline) (ΔHT1, ΔHT2, and ΔHT3); (3) 
density of the newly formed bone located 1 mm below the top of 
the implant platform, assessed using the Hounsfield unit (HU) scale 
with computed-tomography image-processing software (OnDe-
mand3D®, CyberMed, Seoul, Korea) (bone density of HT1).
Histological analysis
After a healing period of 16 weeks, when there was sufficient 
keratinized tissue around the top of the implant cover screw, a 
thin strip-shaped soft-tissue biopsy sample was obtained prior to 
performing re-entry surgery and the connection of the abutment. 
The biopsy samples were fixed in 10% neutral formalin for 10 days, 
and then trimmed and dehydrated in a graded series of alcohol 
solutions. All specimens were stained with hematoxylin-eosin and 
Masson’s trichrome stains. The slides were observed under a light 
microscope (BX50, Olympus, Tokyo, Japan).
Research protocol alteration
During concurrent research that is currently still in progress, we 
determined that the use of different bone substitutes in the NCM 
and DCM groups interfered with evaluations of membrane efficien-
cy. Therefore, after obtaining re-approval from the IRB, we used the 
same bone graft materials (BioOss®) in both groups, and altered the 
study to focus on the clinical feasibility of the membrane.
Statistical analysis
The mean±standard deviation values and 95% confidence in-
tervals were estimated for each study group. Statistical analyses 
were performed with IBM SPSS Statistics (Version 21.0, IBM Corp, 
Armonk, NY, USA), using independent t-tests to compare the re-
sults between the NCM and DCM groups (P<0.05).
 
RESULTS
Patient enrollment
The 30 enrolled patients who fulfilled the inclusion and exclu-
sion criteria comprised 16 males and 14 females with a mean age 
of 53.3 years (range, 31 to 75 years). Two patients dropped out 
during the follow-up: one patient in the DCM group showed signs 
of local infection such as gingival swelling, redness, and pus dis-
charge at the 4-week checkup, and so the implant fixture was re-
moved; the other patient was in the NCM group and showed early 
exposure of the cover screw at the 8-week checkup, and so an 
HT1
HT2
HT3
1 mm
1 mm
1 mm
Figure 1. Mid-cross-sectional image of the implant placement site, showing 
measurement of horizontal thickness (HT) after augmentation and at the 
time of re-entry surgery. HT was calculated at three levels: 1, 2, and 3 mm 
below the top of the implant platform.
GBR with DHT cross-linked collagen membrane
dx.doi.org/10.5051/jpis.2015.45.6.229
www.jpis.org232
emergency surgical procedure involving healing around the abut-
ment connection was performed (Figure 2). The remaining 28 pa-
tients (mean age, 53.4 years; range, 31 to 75 years) experienced no 
critical adverse events (Table 1).
The implants were distributed as follows: incisor, n=10 (35.7%); 
bicuspid, n=7 (25%); and molar, n=11 (39.3%). The 30 implants 
investigated in these patients comprised the following 4 models, 
all of which had an internal-connection design: Implantium and 
NR line® (Dentium), n=22 (78.6%); TS III® (Osstem), n=2 (7.1%); 
Bone Level® (Straumann), n=3 (10.7%); and Luna® (Shinhung), 
n=1 (3.6%). The diameter of the most commonly used implant 
was 4.8 mm (n=8, 28.6%), while the other implants had the fol-
lowing diameters: 3.8 mm (n=8, 28.6%), 4.3 mm (n=5, 17.9%), 3.3 
mm (n=2, 7.1%), and 3.6, 4.1, 4.5, 5.0, and 6.0 mm (n=1 each, 
17.9%). The implants had the following lengths: 10 mm (n=19, 
67.9%), 8 mm (n=5, 17.9%), 12 mm (n=2, 7.1%), and 8.5 and 9 
mm (n=1 for each, 7.1%, Table 2).
Clinical findings
In the present study we attempted to determine the clinical fea-
sibility of using DCM compared with NCM for treating human 
Figure 2. Flow chart of patient enrollment and reasons for exclusion. NCM: non-cross-linked native collagen membrane; DCM: dehydrothermally cross-linked 
collagen membrane; CBCT: cone-beam computed tomography.
Baseline
7–10 Days
4 Weeks
48 Weeks
16 Weeks
Drop-out (infection)
(DCM group, n=1)
Buccal dehiscence defect ≤3 mm (n=13)
Drop-out (cover screw exposure)
(NCM group, n=1)
DCM (n=15)
Assessment for eligibility and enrollment (n=43)
Initial implant surgery
Randomization, CBCT (n=30)
Follow-up and suture removal (n=30)
Follow-up (n=30)
Follow-up (n=29)
Data analysis (n=28)
Re-entry surgery Biopsy, CBCT (n=28)
NCM (n=15)
Table 1. Characteristics of enrolled patients in the two study groups.
Characteristic NCM group DCM group Total
Sample size 14 14 28
Gender
   Male 9 5 14
   Female 5 9 14
Age
   Mean age (years) 52.1 54.6 53.3
   Age range (years) 31–71 41–75 31–75
Data are n values except where indicated otherwise.
NCM: non-cross-linked native collagen membrane, DCM: dehydrothermally cross-linked 
collagen membrane.
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Table 3. Clinical measurements of horizontal and vertical dehiscence defects.
NCM group (mm, n=14) DCM group (mm, n=14) P-value
DW
   Baseline 3.8±1.3 3.5±1.1 0.444
   16 weeks 0.4±0.9 1.7±1.6 0.010a)
DH
   Baseline 5.1±2.4 4.5±2.2 0.436
   16 weeks 0.2±0.6 1.1±1.2 0.018a)
ΔDW 3.5±1.2 1.7±2.2 0.016a)
ΔDH 5.0±2.5 2.9±2.3 0.031a)
Data are mean±SD values.
NCM: non-cross-linked native collagen membrane, DCM: dehydrothermally cross-linked 
collagen membrane, DW: defect width, DH: defect height, ΔDW: DW (re-entry surgery) 
– DW (baseline), ΔDH: DH (re-entry surgery) – DH (baseline).
a)Statistically significant difference in clinical measurements between the two groups 
(P<0.05).
Table 4. Visual analog scale (VAS) scores assessing the ease of membrane ma-
nipulation and maintenance (0: very good, 10: very poor).
Assessment NCM group (n=14) DCM group (n=14) P-value
Manipulation 0.5±1.0 1.3±1.7 0.119
Maintenance 0.3±0.7 1.3±1.1 0.012a)
Data are mean±SD values.
NCM: non-cross-linked native collagen membrane, DCM: dehydrothermally cross-linked 
collagen membrane.
a)Statistically significant difference between the two groups (P<0.05).
peri-implant dehiscence defects. We therefore conducted experi-
ments that excluded bone graft materials from the evaluations, 
and assessed only the membranes themselves.
Five defect sites (two sites in the NCM group and three sites in the 
DCM group) showed soft-tissue dehiscence defects and membrane 
exposure during the early healing period. Despite the presence of 
plaque accumulation and signs of mild inflammation around the 
soft-tissue dehiscence defects, additional necrosis and secondary 
dehiscence defects did not occur. Spontaneous secondary closures 
were successfully completed, and no significant differences were 
observed between the two groups at the 8-week follow-up.
The DW value decreased from 3.8±1.3 to 0.4±0.9 mm in the 
NCM group and from 3.5±1.1 to 1.7±1.6 mm in the DCM group; 
the corresponding ΔDW values were 3.5±1.2 and 1.7±2.2 mm, re-
spectively. Similarly, the DH value decreased from 5.1±2.4 to 
0.2±0.6 mm in the NCM group and from 4.5±2.2 to 1.1±1.2 mm 
in the DCM group, with corresponding ΔDH values of 5.0±2.5 and 
2.9±2.3 mm, respectively. The ΔDW and ΔDH values were statisti-
cally significant between groups (P=0.016 and P=0.031, respec-
tively; Table 3).
The clinical assessment of the ease of manipulation and mainte-
nance was based on the VAS scores in the two groups. The VAS 
score for membrane manipulation did not differ significantly be-
tween the NCM group (0.5±1.0; range, 0 to 3) and the DCM group 
(1.3±1.7; range, 0 to 5; P=0.119). In contrast, the VAS score for the 
maintenance of augmented bone substitutes did differ significantly 
between the two groups: 0.3±0.7 (range, 0 to 2) in the NCM group 
and 1.3±1.1 (range, 0 to 3) in the DCM group (P=0.012, Table 4).
Radiographic findings
The mean HT and corresponding ΔHT values were comparable in 
the two groups (Table 5). The HT values decreased and the corre-
sponding ΔHT values increased by similar amounts in the two 
groups, and there were no statistically significant differences 
among any of the ΔHT values (Table 4).
The bone density of HT1 as assessed at the time of re-entry sur-
gery did not differ significantly between the NCM group (769.5±2 
18.2 HU; range, 421.1 to 1163.7 HU) and the DCM group (739.6± 
275.1 HU; range, 280.4 to 1179.4 HU; P=0.752).
Table 2. Characteristics of implants.
Characteristic NCM group (n=14)
DCM group 
(n=14) Total
Implant system
   Implantium and NR line, Dentium  9 13 22
   TS III, Osstem  1  1  2
   Bone level, Straumann  3  0  3
   Shinhung, Luna implant system  1  0  1
Location
   Incisor region  7  3 10
   Bicuspid region  2  5  7
   Molar region  5  6 11
Diameter (mm)
   3.3  2  0  2
   3.6  0  1  1
   3.8  3  5  8
   4.1  1  0  1
   4.3  3  2  5
   4.5  0  1  1
   4.8  3  5  8
   5.0  1  0  1
   6.0  1  0  1
Length (mm)
   8.0  0  5  5
   8.5  1  0  1
   9.0  0  1  1
   10.0 13  6 19
   12.0  0  2  2
Data are n values except where indicated otherwise.
NCM: non-cross-linked native collagen membrane, DCM: dehydrothermally cross-linked 
collagen membrane.
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Histological findings
There was insufficient keratinized gingiva around the implant in 
six patients, and so histological slides from the remaining 10 DCM 
and 12 NCM specimens were examined by light microscopy. Soft 
tissue biopsy was performed to confirm the presence of the re-
maining membrane fragment. Little Newly formed bone was ob-
served around the grafted bone particles, which were dispersed 
above the bone bed in all groups. No membrane remnants were 
observed in any samples of the NCM group. In contrast, partially 
resorbed DCM leaflets exhibiting structural integrity were clearly 
identified between the gingival connective tissue and bone substi-
tute materials in the DCM group at magnifications of 100- and 
200-fold (Figure 3). Inflammatory processes were not considered 
to be present in either group, and so these histological results indi-
cate that DCM exhibited sufficient biocompatibility.
 
DISCUSSION
The aim of this study was to determine the clinical feasibility of 
using DCM compared with NCM for treating human peri-implant 
dehiscence defects. Both types of collagen membrane demonstrat-
ed significant improvements in all clinical and radiographic param-
eters, with no signs or symptoms of severe complications during 
the postoperative experimental period.
The horizontal and vertical dehiscence defects did not differ sig-
nificantly between the DCM and NCM groups at baseline. Re-entry 
surgery was performed after 16 weeks, at which time the clinical 
condition of the defects was considered to be acceptable, thereby 
confirming the successful occurrence of GBR. Premature exposure 
of membranes was found in two samples in the NCM group (14.3%) 
and three samples in the DCM group (21.4%). It is generally known 
that soft-tissue dehiscence defects and exposure of membrane lead 
to impaired bone healing and significant deterioration of the defect 
[23,24]. However, notable reduction of bone regeneration and im-
paired wound healing was not observed in the DCM group. This is 
consistent with the finding of Moses et al. [25] that a cross-linked 
collagen membrane was advantageous for GBR procedures. The re-
sults obtained in the previous and present studies together indicate 
that the cross-linking method prevents biodegradation of the col-
lagen membrane and promotes soft-tissue healing without any 
signs of infection during the secondary healing period [25,26].
Table 5. Measurements made in the radiographic analyses.
NCM group (mm, n=14) DCM group (mm, n=14) P-value
HT1
   Baseline 2.3±0.8 2.6±0.8 0.375
   16 weeks 1.7±1.2 1.6±1.2 0.734
HT2
   Baseline 2.6±0.7 3.2±0.9 0.039a)
   16 weeks 2.1±1.1 2.5±1.4 0.436
HT3
   Baseline 2.7±0.8 3.9±1.2 0.004a)
   16 weeks 2.4±1.4 3.0±1.4 0.329
ΔHT1 0.6±0.9 1.0±1.1 0.277
ΔHT2 0.5±0.7 0.8±1.1 0.383
ΔHT3 0.3±0.9 1.0±1.0 0.080
Data are mean±SD values.
HT1, HT2, and HT3: horizontal thicknesses at 1, 2, and 3 mm below the top of the 
implant platform, ΔHTx: HTx (re-entry surgery) – HTx (baseline), NCM: non-cross-linked 
native collagen membrane, DCM: dehydrothermally cross-linked collagen membrane.
a)Statistically significant difference between the two groups in radiographic 
measurements (P<0.05).
A B
Figure 3. Histological images from the DCM group at the time of re-entry surgery. (A, B) Partially resorbed collagen membrane leaflets exhibiting structural in-
tegrity and some blood vessels (BVs) were observed. Bone substitute materials (BM) were surrounded by collagen membranes and BVs. New bone (NB) forma-
tion was observed on the BM surface (A: Masson's trichrome stains, ×100, Scale bars, 500 μm; B: Masson's trichrome stains, ×200, Scale bars, 200 μm).
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The measurements of HT1, HT2, and HT3 revealed decreases at 
16 weeks in both groups compared to baseline, but there were no 
statistically significant intergroup differences. The bone density of 
HT1 was measured using CBCT to predict the quality of bone re-
modeling. The average bone density in both groups was within the 
general acceptable range (D1 to D3) for bone quality [27]. Regard-
less of the presence of premature membrane exposure, no signifi-
cant radiographic or clinical differences were evident.
Histological analyses revealed that the NCM applied at the defect 
site was significantly absorbed at 4 weeks and almost completely 
absorbed at 16 weeks [28]. NCM reportedly shows rapid degrada-
tion and good biocompatibility, whereas physically cross-linked 
membrane shows slow degradation but with a similarly low cyto-
toxicity [29,30]. However, it was difficult to verify these findings 
with the histological results obtained at 16 weeks in the present 
study. The remaining unabsorbed DCM fragment was observed his-
tologically only in the DCM group, whereas no NCM fragments 
were observed in the NCM group. This histological result for the 
DCM group was similar to that for the NCM group and it confirmed 
the presence of good biocompatibility. However, because this study 
conducted biopsy sampling in the keratinized gingival tissue zone 
above the cover screw, the amount of new bone and pattern of 
bone resorption could not be evaluated, and only some grafted 
bone particles and integration into new bone were observed.
Depending on the type, structure, degree of cross-linking, and 
surface-treatment method, it is crucial to determine the mechani-
cal, chemical, and physical properties of the collagen membrane 
[11,31]. The DHT cross-linking technique increases the number of 
amino-acid side chains between collagen molecules and unwinds 
the triple-helix structure of collagen [32]. The fibroblast binding 
sites (α1β1 and α2β1 integrins) are subsequently modified, but it is 
not yet clear if these physical changes determine the major me-
chanical and biochemical characteristics of DCM [9,33]. Compared 
to the conventional DHT cross-linking method, which requires 3 to 
5 days of dehydration, the collagen membrane used in the present 
study was dehydrated at 100°C under vacuum pressure (1 torr), 
which reduced the dehydration period to 24 hours. Like the physi-
cal cross-linking method using UV radiation, this represents a more 
effective and rapid cross-linking method [32].
The previous and present studies found that DCM was stiffer and 
more hydrophobic than DCM, which is attributable to the increased 
binding between the carboxyl and amino groups of the adjacent 
collagen molecules [33,34]. Despite the constraints of the cross-
linking technique, when performing GBR at the time of implant 
placement it was found that the membrane could be easily manip-
ulated, without any significant differences between the two groups. 
While there was a statistically significant difference in the clini-
cian’s subjective judgement of the maintenance of localized bone 
particles, there was no clinically meaningful difference in the VAS 
score between the NCM (0.3±0.7) and DCM (1.3±1.1) groups 
(P=0.119). Therefore, clinicians can use the DHT cross-linking meth-
od to control the biodegradation rate of the membrane, allowing 
the easy and effective use of DCM to achieve successful bone aug-
mentation.
In this study, the different types of implants fixtures had the 
same SLA surfaces with bone level fixtures; in other words, they 
had very similar designs and surfaces. A recent systematic review 
revealed no significant difference between SLA implants types in 
success rate or marginal bone loss [35]; therefore, although this 
may pose as a limitation, its effect can be assumed to be minimal. 
Moreover, the change in bone graft material during the study that 
was necessitated by our parallel research findings also acts as a lim-
itation. Despite the limitations, the present randomized clinical 
study indicates that the clinical expediency, biocompatibility, and 
more enhanced degradation resistance are similar for DCM and 
NCM. DCM can therefore be used for GBR around serious peri-im-
plant defects.
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